QEEG-guided neurofeedback in the treatment of obsessive compulsive disorder

Journal of Neurotherapy

Volumn 7, Issue 2, 2003, Pages 25-52

  Hammond, D Corydon ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Biofeedback; EEG; Neurofeedback; Obsessive compulsive disorder; OCD; Quantitative EEG

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; CLOMIPRAMINE; CLONAZEPAM; FLUOXETINE; HALOPERIDOL; METHYLPHENIDATE; NEFAZODONE; PAROXETINE; SERTRALINE; VENLAFAXINE;

ADULT; ALPHA RHYTHM; ANXIETY; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CASE REPORT; CLINICAL PROTOCOL; CONTROLLED STUDY; DEPRESSION; ELECTROENCEPHALOGRAPHY; EXTRAVERSION; FAMILY; FEEDBACK SYSTEM; FEMALE; FOLLOW UP; HUMAN; INTROVERSION; MALE; MINNESOTA MULTIPHASIC PERSONALITY INVENTORY; NEUROLOGIC EXAMINATION; OBSESSIVE COMPULSIVE DISORDER; OUTCOMES RESEARCH; PRIORITY JOURNAL; PSYCHOSOCIAL WITHDRAWAL; QUANTITATIVE ANALYSIS; RATING SCALE; REVIEW; SCORING SYSTEM; SYMPTOMATOLOGY; VALIDATION PROCESS;

EID: 0142030686     PISSN: 10874208     EISSN: None     Source Type: Journal    
DOI: 10.1300/J184v07n02_03     Document Type: Review

References (88)

1. Abercrombie, H. C., Larson, C. L., Ward, R. T., Schaefer, S. M., Holden, J. E., Perlman, S. B., et al. (1996). Metabolic rate in the amygdala predicts negative affect and depression severity in depressed patients: A FDG-PET study. Neuroimage, 3 (2), S217.
2. Abramowitz, J. (1997). Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: A quantitative review. Journal of Consulting & Clinical Psychology, 65, 44-52.
3. Ackerman, D. L., & Greenland, S. (2002). Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorder. Journal of Clinical Psychopharmacology, 22 (3), 309-317.
4. Ackerman, D. L., Greenland, S., Bystritsky, A., & Katz, R. J. (1996). Relationship between early side effects and therapeutic effects of clomipramine therapy in OCD. Journal of Clinical Psychopharmacology, 16, 324-328.
5. Antonuccio, D. O., Danton, W. G., DeNelsky, G. Y., Greenberg, R. P., & Gordon, J. S. (1999). Raising questions about antidepressants. Psychotherapy & Psychosomatics, 68, 3-14.
6. Baxter, L. R., Schwartz, J. M., Mazziotta, J. C., Phelps, M. E., Pahl, J. J., Guze, B. H., et al. (1988). Cerebral glucose metabolic rates in non-depressed patients with obsessive-compulsive disorder. American Journal of Psychiatry, 145, 1560-1563.
7. Baxter, L., Phelps, M., Mazziotta, J., Guze, B. H., Schwartz, J. M., & Selin, C. (1987). Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Archives of General Psychiatry, 44, 211-218.
8. Baxter, L., Schwartz, J. M., Bergman, K. S., Szuba, M. P., Guze, B. H., Mazziotta, J. C., et al. (1992). Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Archives of General Psychiatry, 49, 681-688.
9. Benkelfat, C., Phelps, M., Mazziotta, J., Guze, B. H., Schwartz, J. M., & Selin, R. M. (1990). Local cerebral glucose metabolic rates in obsessive-compulsive disorder patients treated with clomipramine. Archives of General Psychiatry, 147, 846-848.
10. Brody, A. L., Saxena, S., Schwartz, J. M., Stoessel, P. W., Maidment, K., Phelps, M. E., et al. (1998). FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder. Psychiatry Research, 84, 1-6.
11. Burns, G. L., Keortge, S., Formea, G., & Sternberger, L. (1996). Revision of the Padua Inventory of obsessive-compulsive symptoms: Distinctions between worry, obsessions, and compulsions. Behaviour Research & Therapy, 34, 163-173.
12. Canli, T., Desmond, J. E., Zhao, Z., Glover, G., & Gabrieli, J. D. (1998). Hemispheric asymmetry for emotional stimuli detected with fMRI. Neuroreport, 9, 3233-3239.
13. Chua, P., Krams, M., Toni, I., Passingham, R., & Dolan, R. (1999). A functional anatomy of anticipatory anxiety. Neuroimage, 9, 563-571.
14. Davidson, R. J. (1992). Emotion and affective style: Hemispheric substrates. Psychological Science, 3, 39-43.
15. Davidson, R. J. (1998a). Affective style and affective disorders: Perspectives from affective neuroscience. Cognition & Emotion, 12, 307-320.
16. Davidson, R. J. (1998b). Anterior electrophysiological asymmetries, emotion, and depression: Conceptual and methodological conundrums. Psychophysiology, 35, 607-614.
17. Dehaene, S., Posner, M. I., & Tucker, D. M. (1994). Localization of a neural system for error detection and compensation. Psychological Science, 5, 303-305.
18. Dolan, R. J., Fletcher, P., Morris, J., Kapur, N., Deakin, J. F., & Frith, C. D. (1996). Neural activation during covert processing of positive emotional facial expressions. Neuroimage, 4, 194-200.
19. Dolski, I. V., Malmstadt, J. R., Schaefer, S. M., Larson, C. L., Abercrombie, H. C., Ward, R. T., et al. (1996). EEG-defined left versus right frontally activated groups differ in metabolic asymmetry in the amygdala. Psychophysiology, 33, S35.
20. Dougherty, D. D., Baer, L., Cosgrove, G. R., Cassem, E. H., Price, B. H., Nierenberg, A. A., et al. (2002). Prospective long-term follow-up of 44 patients who received cingulotomy for treatment-refractory obsessive-compulsive disorder. American Journal of Psychiatry, 159 (2), 269-275.
21. Flor-Henry, P., Yeudall, L., Koles, Z., & Howarth, B. (1979). Neuropsychological and power spectral EEG investigations of the obsessive-compulsive subjects. Biological Psychiatry, 14, 119-130.
22. Foa, E. B., Steketee, G. S., & Ozarow, B. J. (1985). Behavior therapy with obsessive-compulsives: From theory to treatment. In M. Mavissakalian, S. M. Turner, & L. Michelson (Eds.), Obsessive-Compulsive Disorder: Psychological and pharmacological treatment (pp. 49-129). New York: Plenum Press.
23. Foa, E. B., & Franklin, M. E. (2001). Obsessive-compulsive disorder. In D. H. Barlow (Ed.), Clinical handbook of psychological disorders (3rd ed., pp. 209-263). New York: Guilford.
24. Gehring, W. J., Coles, M. G. H., Meyer, D. E., & Donchin, E. (1990). The error-related negativity: An event-related brain potential accompanying errors. Psychophysiology, 27, S34.
25. Gehring, W. J., Goss, B., Coles, M. G. H., Meyer, D. E., & Donchin, E. (1993). A neural system for error detection and compensation. Psychological Science, 4, 385-390.
26. Gehring, W. J., Himle, J., & Nisenson, L. G. (2000). Action-monitoring dysfunction in obsessive-compulsive disorder. Psychological Science, 11, 1-6.
27. George, M. S., Ketter, T. A., Parekh, P. I., Horwitz, B., Herscovitch, P., & Post, R. M. (1995). Brain activity during transient sadness and happiness in healthy women. American Journal of Psychiatry 152, 341-351.
28. Gloor, P. (1976). Generalized and widespread paroxysmal abnormalities. In A. Redmond (Ed.), Handbook of Electroencephalography & Clinical Neurophysiology, Volume 132, Part B. Amsterdam: Elsevier.
29. Goodman, W. K., McDougle, C. J., & Price, L. H. (1992). Pharmacotherapy of obsessive compulsive disorder. Journal of Clinical Psychiatry, 53(Suppl.), 29-37.
30. Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Delgado, P., Heninger, G. R., et al. (1989). The Yale-Brown Obsessive Compulsive Scale. II. Validity. Archives of General Psychiatry, 46, 1012-1016.
31. Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Fleischmann, R. L., Hill, C. L., et al. (1989). The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Archives of General Psychiatry, 46, 1006-1011.
32. Greist, J. H. (1990). Treatment of obsessive compulsive disorder: Psychotherapies, drugs, and other somatic treatment. Journal of Clinical Psychiatry, 51 (8), 44-50.
33. Greenberg, B. D., Ziemann, U., Cora-Locatelli, G., Harmon, A., Murphy, D. L., Keel, J. C., et al. (2000). Altered cortical excitability in obsessive-compulsive disorder. Neurology, 54, 142-147.
34. Hammond, D. C. (2001a). Neurofeedback treatment of depression with the Roshi. Journal of Neurotherapy, 4 (2), 45-56.
35. Hammond, D. C. (2001b). Comprehensive neurofeedback bibliography. Journal of Neurotherapy, 5 (1-2), 113-128.
36. Hajcak, G., & Simons, R. F. (2002). Error-related brain activity in obsessive-compulsive undergraduates. Psychiatry Research, 110, 63-72.
37. Harris, G. J., Pearlson, G. D., & Hoehn-Saric, R. (1993). Single photon emission computed tomography in obsessive-compulsive disorder. Archives of General Psychiatry, 50 (6), 498-501.
38. Heller, W., Etienne, M. A., & Miller, G. A. (1995). Patterns of perceptual asymmetry in depression and anxiety: Implications for neuropsychological models of emotion and psychopathology. Journal of Abnormal Psychology, 104, 327-333.
39. Heller, W., Nitschke, J. B., Etienne, M. A., & Miller, G. A. (1997). Patterns of regional brain activity differentiate types of anxiety. Journal of Abnormal Psychology, 106 (3), 376-385.
40. Holroyd, C. B., Dien, J., & Coles, M. G. H. (1998). Error-related scalp potentials elicited by hand and foot movements: Evidence for an output-independent effor-processing system in humans. Neuroscience Letters, 242, 65-68.
41. Insel, T. R., Donnelly, E. R., Lalakea, M. L., Alterman, I. S., & Murphy, D. L. (1983). Neurological and neuropsychological studies of patients with obsessive-compulsive disorder. Biological Psychiatry, 18, 741-751.
42. Isotani, T., Tanaka, H., Lehmann, D., Pascual-Marqui, R. D., Kochi, K., Saito, N., et al. (2001). Source localization of EEG activity during hypnotically induced anxiety and relaxation. International Journal of Psychophysiology, 41, 143-153.
43. Jenike, M. A., Baer, L., Ballantine, T., Martuza, R. L., Tynes, S., Giriunas, I., et al. (1991). Cingulotomy for refractory obsessive-compulsive disorder: A long-term follow-up of 33 patients. Archives of General Psychiatry, 48, 548-555.
44. Jenike, M. A., & Brotman, A. W. (1984). The EEG in obsessive-compulsive disorder. Journal of Clinical Psychiatry, 45, 122-124.
45. Karno, M., Golding, J. M., Sorenson, S. B., & Burnam, M. A. (1988). The epidemiology of obsessive-compulsive disorder in five U.S. communities. Archives of General Psychiatry, 45, 1094-1099.
46. Kirsch, I., & Sapperstein, G. (1998). Listening to Prozac, but hearing placebo? A meta-analysis of antidepressant medication. Prevention & Treatment, 1, 0002a. (A peer-reviewed APA journal available at http://www.journals.apa.org/prevention/volume1/pre0010002a.html)
47. Kuskowski, M., Malone, S., Kim, S., Dysken, M., Okaya, A., & Christensen, K. (1993). Quantitative EEG in obsessive compulsive disorder. Biological Psychiatry, 33, 423-430.
48. Leocani, L., Locatelli, M., Bellodi, L., Fornara, C., Henin, M., Magnani, et al. (2001). Abnormal pattern of cortical activation associated with voluntary movement in obsessive-compulsive disorder: An EEG study. American Journal of Psychiatry, 158 (1), 140-142.
49. Luu, P., Collins, P., & Tucker, D. M. (2000). Mood, personality, and self-monitoring: Negative affect and emotionality in relation to frontal lobe mechanisms of error monitoring. Journal of Experimental Psychology: General, 129, 43-60.
50. Machlin, S. R., Harris, G. J., & Pearlson, G. D. (1991). Elevated medial-frontal cerebral blood flow in obsessive-compulsive patients: A SPECT study. American Journal of Psychiatry, 148, 1240-1242.
51. MacCrimmon, D. J., & Arato, H. (1991). Interhemispheric serotonergic asymmetry reflected in topographic pharmaco-EEG. Psychiatry Research: Neuroimaging, 40 (1), 91-93.
52. Malloy, P., Rasmussen, S., Braden, W., & Haier, R. J. (1989). Topographic evoked potential mapping in obsessive-compulsive disorders: Evidence of frontal lobe dysfunction. Psychiatry Research, 28(1), 63-71.
53. Mas, F., Prichep, L. S., John, E. R., & Levine, R. (1993). Neurometric Q-EEG subtyping of obsessive compulsive disorders. In K. Maurer (Ed.), Imagining of the brain in psychiatry and related fields (pp. 277-280). Heidelberg, Berlin, Germany: Springer-Verlag.
54. Moncrieff, J. (2001). Are antidepressants overrated? A review of methodological problems in antidepressant trials. Journal of Nervous & Mental Disease, 189 (5), 288-295.
55. Moncrieff, J., Wessely, S., & Hardy, R. (1998). Meta-analysis of trials comparing antidepressants with active placebos. British Journal of Psychiatry, 172, 227-231.
56. Nakamura, S., Sadato, N., Oohashi, T., Nishina, E., Fuwamoto, Y., & Yonekura, Y. (1999). Analysis of music-brain interaction with simultaneous measurement of regional cerebral blood flow and electroencephalogram beta rhythm in human subjects. Neuroscience Letters, 275 (3), 222-226.
57. Naveteur, J., Roy, J. C., Ovelac, E., & Steinling, M. (1992). Anxiety, emotion and cerebral blood flow. International Journal of Psychophysiology, 13, 137-146.
58. Nordahl, T. E., Benkelfat, C., Semple, W. E., Gross, M., King, A. C., & Cohen, R. M. (1989). Cerebral glucose metabolic rates in obsessive-compulsive disorder. Neuropsychopharmacology, 2, 23-28.
59. Pacella, B. L., Polatin, P., & Nagler, S. H. (1944). Clinical and EEG studies in obsessive-compulsive disorder. American Journal of Psychiatry, 100, 830-838.
60. Pato, M., Zohar-Kadouch, R., & Zohar, J. (1988). Return of symptoms after discontinuation of clomipramine in patients with obsessive compulsive disorder. American Journal of Psychiatry, 145, 1521-1525.
61. Perani, D., Colombo, C., Bressi, S., Bonfanti, A., Grassi, F., Scarone, S., et al. (1995). 18F]FDG PET study in obsessive-compulsive disorder: A clinical/metabolic correlation study after treatment. British Journal of Psychiatry, 156, 244-250.
62. Perros, R., Young, E., Ritson, J., Price, G., & Mann, P. (1992). Power spectral EEG analysis and EEG variability in obsessive-compulsive disorder. Brain Topography, 4 (3), 187-192.
63. Pfurtscheller, G., Pichler-Zalaudek, K., Ortmayr, B., Kiez, J., & Reisecker, F. (1998). Journal of Clinical Neurophysiology, 15, 243-250.
64. Piacentini, J., & Bergman, R. L. (2000). Obsessive-compulsive disorder in children. Psychiatric Clinics in North America, 23 (3), 519-533.
65. Pizzagalli, D. A., Nitschke, J. B., Oakes, T. R., Hendrick, A. M., Horras, K. A., Larson, C. L., et al. (2002). Brain electrical tomography in depression: The importance of symptom severity, anxiety, and melancholic features. Biological Psychiatry, 52, 73-85.
66. Posner, M. I., & Rothbart, M. K. (1998). Attention, self-regulation and consciousness. Philosophical Transitions of the Royal Society of London Series B-Biological Sciences, 353, 1-13.
67. Prichep, L. S., Mas, F., & John, E. R. (1989). Neurometric subtyping of obsessive compulsive disorders in psychiatry: A world perspective. Chapter in C. N. Stefanis, A. D. Rabavilas, & C. R. Soldatos (Eds.), Proceedings of the VIII World Congress of Psychiatry, Athens, October 12-19, 1989 (pp. 557-562). New York: Elsevier Science.
68. Prichep, L. S., Mas, F., Hollander, E., Liebowitz, M., John, E. R., Alman, M., et al. (1993). Quantitative electroencephalography (QEEG) subtyping of obsessive compulsive disorder. Psychiatry Research, 50 (1), 25-32.
69. Rauch, S. L. (2000). Neuroimaging research and the neurobiology of obsessive-compulsive disorder: Where do we go from here? Biological Psychiatry, 47, 168-170.
70. Rauch, S. L., Whalen, P. J., Dougherty, D., & Jenike, M. A. (1998). Neurobiologic models of obsessive-compulsive disorder. In M. A. Jenike, L. Baer, & W. E. Minichiello (Eds.), Obsessive-compulsive disorders: Practical management (pp. 222-253). St. Louis: Mosby.
71. Reivich, M., Alavi, A., & Gur, R. C. (1984). Positron emission tomographic studies of perceptual tasks. Annals of Neurology, 15, (Suppl.), S61-S65.
72. Rockwell, F. V., & Simons, D. J. (1947). The electroencephalogram and personality organization in the obsessive compulsive reactions. Archives of Neurology & Psychiatry, 57, 71-80.
73. 133Xe cerebral blood flow and cerebral 99m-HMPAO uptake in unmedicated obsessive-compulsive disorder patients and matched normal control subjects: Determination by high-resolution single-photon emission computed tomography. Archives of General Psychiatry, 49, 695-702.
74. Sawle, G. V., Hymas, N. F., & Lees, A. J. (1991). Obsessive slowness: Functional studies with positron emission tomography. Brain, 114, 2191-2202.
75. Saxena, S., Brody, A. L., Schwartz, J. M., & Baxter, L. R. (1998). Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. British Journal of Psychiatry (Supplement), 35, 26-38.
76. Schwartz, J. M., Stoessel, P. W., Baxter, L. R., Martin, K. M., & Phelps, M. E. (1996). Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Archives of General Psychiatry, 53, 109-113.
77. Silverman, J. S., & Loychik, S. G. (1990). Brain-mapping abnormalities in a family with three obsessive-compulsive children. Journal of Neuropsychiatry & Clinical Neurosciences, 2, 319-322.
78. Simpson, H. B., Tenke, C. E., Towey, J. B., Liebowitz, M. R., & Bruder, G. E. (2000). Symptom provocation alters behavioral ratings and brain electrical activity in obsessive-compulsive disorder: A preliminary study. Psychiatry Research, 95(2), 149-155.
79. Stapleton, J. M., Morgan, M. J., Liu, X., Yung, B. C., Phillips, R. L., Wong, D. F., et al. (1997). Cerebral glucose utilization is reduced in second test session. Journal of Cerebral Blood Flow & Metabolism, 17, 704-712.
80. Sterman, M. B. (2000). Basic concepts and clinical findings in the treatment of seizure disorders with EEG operant conditioning. Clinical Electroencephalography, 31 (1), 45-55.
81. Stewart, R. S., Devous, M. D., Rush, A. J., Lane, L., & Bonte, F. J. (1988). Cerebral blood flow changes during sodium-lactate-induced panic attacks. American Journal of Psychiatry, 145, 442-449.
82. Swedo, S. E., Pletrini, P., Leonard, H. L., Schapiro, M. G., Rettew, D. C., Goldberger, E. L., et al. (1992). Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder: Revisualization during pharmacology. Archives of General Psychiatry, 49, 690-694.
83. Swedo, S. E., Schapiro, M. G., & Grady, C. L. (1989). Cerebral glucose metabolism in childhood onset obsessive-compulsive disorder. Archives of General Psychiatry, 46, 518-523.
84. Szeszko, P. R., Robinson, D., Alvir, J. M., Bilder, R. M., Lencz, T., Ashtari, M., et al. (1999). Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder. Archives of General Psychiatry, 56 (10), 913-919.
85. Thomson, R. (1982). Side effects and placebo amplification. British Journal of Psychiatry, 140, 64-68.
86. Troisi, E., Silvestrini, M., Matteis, M., Monaldo, B. C., Vernieri, F., & Caltagirone, C. (1999). Emotion-related cerebral asymmetry: Hemodynamics measured by functional ultrasound. Journal of Neurology, 246, 1172-1176.
87. Ursu, S., van Veen, V., Siegle, G., MacDonald, A., Stenger, A., & Carter, C. (2001, March). Executive control and self-evaluation in obsessive-compulsive disorder: An event-related fMRI study. Poster presented at the Cognitive Neuroscience Society Meeting, New York, Cited in Hajcak & Simons, 2002.
88. Wiedemann, G., Pauli, P., Dengler, W., Lutzenberger, W., Birbaumer, N., & Buckkremer, G. (1999). Frontal brain asymmetry as a biological substrate of emotions in patients with panic disorders. Archives of General Psychiatry, 56, 78-84.